Christopher Murdock PhD, CQA Eli Lilly and Company

Chris Murdock, PhD holds a BS and MS in Microbiology from the University of Memphis and a PhD from Rutgers University in Molecular Microbiology. Chris has over 35 years of industry experience in microbiology, sterility assurance and sterile quality in both laboratory and operational roles. He has worked in contract manufacturing organizations as well as small, mid-size and large pharmaceutical, biotech and medical device organizations. Dr. Murdock has extensive experience in sterile quality, aseptic processing, nonsterile manufacturing as well as both development and commercial production. Dr. Murdock also has extensive experience in compliance and auditing requirements, has supported and led domestic and international Health Authority inspections and is a ASQ and ISO Certified Auditor and Specialist Microbiologist (NRCM). Chris is the current chair of the Pharmaceutical Microbiology Expert Discussion Group and previously served on the USP Microbiology Water Committee. Chris served as the Co-lead author for the PDA Technical Report TR 13-2, Environmental Monitoring of Facilities Manufacturing Low Bioburden Products, PDA Technical Report TR 88, Microbial Data Deviation Investigations in the Pharmaceutical Industry and PDA Technical Report TR 90 for Contamination Control Strategy Development in Pharmaceutical Manufacturing.